Albert Bourla

Chairman and CEO of Pfizer Inc., Bourla is a healthcare leader known for spearheading breakthroughs in pharmaceuticals, including the rapid development of the COVID-19 vaccine.

Explore Albert Bourla's largest investments on Profit.com, including companies like Pfizer Inc, and their significance in his portfolio.

Albert Bourla’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.

Albert Bourla currently invests in companies such as Pfizer Inc, focusing on sectors like Healthcare.

The largest holding in Albert Bourla’s portfolio is Pfizer Inc, accounting for 100.00% of their total investments.

One of Albert Bourla’s most profitable investments is Pfizer Inc, which has generated a return of 13.73% over the past year.

As of 14 Oct 2026, Albert Bourla’s portfolio is valued at approximately $12.36M, based on the latest filings available on Profit.com.

Yes, you can use Profit.com to follow Albert Bourla’s portfolio and gain insights to build your own investment portfolio.

You can follow Albert Bourla’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.

Stay up-to-date with Albert Bourla’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.